MHLA Medication Assisted Treatment (MAT) Waiver Eligibility Training Opportunity

When:
July 18, 2019 @ 8:00 am – 12:00 pm
2019-07-18T08:00:00-07:00
2019-07-18T12:00:00-07:00
Where:
Community Clinic Association of Los Angeles County
Union Bank Plaza
445 S Figueroa St #2100, Los Angeles, CA 90071
USA
Cost:
Free
Contact:
Training Center

Free My Health LA Medication Assisted Treatment (MAT) Waiver Eligibility Training

My Health LA is proud to announce the upcoming free training on Medications for Addiction Treatment (MAT) Waiver Eligibility.  The goal is to train a diverse range of healthcare professionals in the safe and effective prescribing of opioid medications for the treatment of pain, as well as the treatment of substance use disorders, particularly opioid use disorders, with medication-assisted treatments.  This course will describe the resources needed to offer buprenorphine treatment to patients with opioid use disorder and review DSM-5 criteria for opioid use disorder and the commonly accepted criteria for patients appropriate for office-based treatment of opioid use disorder.

There will be two dates offered, and the training content is the same on both dates. Training covers four hours of CEUs including CMEs in total and is open to physicians, physician assistants and nurse practitioners. Attendees will be required to complete an additional four hours on-line training to receive X-Waiver certification.

Objectives:
1. Assess patients with opioid use disorder for their appropriateness for medications for opioid use disorder.
2. Offer medication management of opioid use disorder with buprenorphine to patients with opioid use disorder.
CULTURAL COMPETENCY/HEALTH DISPARITIES LEARNING OBJECTIVE(S):
3. Discuss the way that culture, race, ethnicity, language, and sociopolitical context interact to shape patient attitudes regarding buprenorphine and recovery from opioid use disorder.
ADDITIONAL LEARNING OBJECTIVES:
4. Compare and contrast the FDA-approved medications for opioid use disorder.
5. Construct a treatment plan involving toxicology testing and ongoing medication management for patients being prescribed buprenorphine for opioid use disorder.

Register Now for July 18 !

Register Now for July 30 !

Presented by Brian Hurley, M.D., M.B.A., DFASAM, Los Angeles County Department of Health Services, Director of Addiction Medicine

Funding for this initiative was made possible (in part) by grant no. 5U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.